ESR1 and breast cancer: In accordance with these findings, it has been shown that RAGE silencing impairs tumor growth and angiogenesis, prevents the recruitment of inflammatory cells and reduces lung and liver metastases in estrogen receptor (ER)-negative BC cells [30].